Clinical, Biochemical and Molecular Evaluations of Ivermectin Mucoadhesive Nanosuspension Nasal Spray in Reducing Upper Respiratory Symptoms of Mild COVID-19 [Corrigendum]

Aref ZF, Bazeed SEES, Hassan MH, et al. Int J Nanomedicine. 2021;16:4063—4072. https://doi.org/10.2147/IJN.S313093 It has come to our attention that there are errors on page 4067 of the published paper. Specifically, Figure 1 and in the Results, Demographic Data of Study Groups section. There are spelling errors throughout the figure artwork. The text “swaps” should read “swabs” and “d-dimmer” should read “D-Dimer”. The correct Figure 1 is shown below. Figure 1 Flow chart of the study design. Results, Demographic Data of Study Groups section, left column, line 13, the text “P = 0 0.7” should read “P = 0.7”. The authors apologize for these errors and advise they do not affect the results of the paper.